CYTOKINE MESSENGER-RNA EXPRESSION IN INFLAMMATORY MULTIPLE-SCLEROSIS LESIONS - DETECTION BY NONRADIOACTIVE IN-SITU HYBRIDIZATION

被引:215
作者
WOODROOFE, MN
CUZNER, ML
机构
[1] Multiple Sclerosis Laboratory, Institute of Neurology, London, WC1N 1PJ
关键词
IN SITU HYBRIDIZATION; MULTIPLE SCLEROSIS; TUMOR NECROSIS FACTOR; INTERFERON-GAMMA; INTERLEUKIN; -6; DIGOXIGENIN;
D O I
10.1016/S1043-4666(05)80008-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The predominant pathological features in the central nervous system (CNS) in multiple sclerosis (MS) are perivascular inflammation and demyelination. The cells in the inflammatory cuff consist mainly of T lymphocytes and macrophages. Cytokines produced by inflammatory cells within the CNS have the potential to enhance local inflammation and promote phagocytosis of myelin by macrophages, resulting in demyelination. Resident brain cells, microglia and astrocytes, also produce cytokines after stimulation in vitro. We have applied the technique of non-radioactive in situ hybridization to examine which cells in the CNS are producing cytokines in MS. Using digoxigenin-labelled oligonucleotide probes we have detected expression of the cytokines IL-1α, IL-2, IL-4, IL-6, IL-10, IFN-γ, TGFβ1 and 2 and TNF-α in frozen sections of CNS tissue from MS cases. The intensity and distribution of the staining for mRNA is cytokine specific, IL-6, IFN-γ and TNF-α predominating in the perivascular inflammatory cuffs, the others being more weakly expressed. Expression of all cytokine mRNAs is stronger in perivascular cells rather than in parenchymal cells, suggesting that circulating inflammatory cells which have crossed the blood brain barrier are the major source of cytokines in MS tissue. © 1993 Academic Press, Inc.
引用
收藏
页码:583 / 588
页数:6
相关论文
共 23 条
[1]   MACROPHAGE POPULATIONS ASSOCIATED WITH MULTIPLE-SCLEROSIS PLAQUES [J].
ESIRI, MM ;
READING, MC .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1987, 13 (06) :451-465
[2]   TUMOR NECROSIS FACTOR IN SERUM AND CEREBROSPINAL-FLUID OF PATIENTS WITH MULTIPLE-SCLEROSIS [J].
FRANCIOTTA, DM ;
GRIMALDI, LME ;
MARTINO, GV ;
PICCOLO, G ;
BERGAMASCHI, R ;
CITTERIO, A ;
DERIL, GVM .
ANNALS OF NEUROLOGY, 1989, 26 (06) :787-789
[3]  
FREI K, 1991, J NEUROIMMUNOL, V31, P147
[4]   A LONGITUDINAL-STUDY ON IL-2, SIL-2R, IL-4 AND IFN-GAMMA IN MULTIPLE-SCLEROSIS CSF AND SERUM [J].
GALLO, P ;
PICCINNO, MG ;
TAVOLATO, B ;
SIDEN, A .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1991, 101 (02) :227-232
[5]  
HARRISON PJ, 1990, IN SITU HYBRIDISATIO
[6]   CYTOKINE ACCUMULATIONS IN CSF OF MULTIPLE-SCLEROSIS PATIENTS - FREQUENT DETECTION OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR BUT NOT INTERLEUKIN-6 [J].
HAUSER, SL ;
DOOLITTLE, TH ;
LINCOLN, R ;
BROWN, RH ;
DINARELLO, CA .
NEUROLOGY, 1990, 40 (11) :1735-1739
[7]   TUMOR NECROSIS FACTOR IDENTIFIED IN MULTIPLE-SCLEROSIS BRAIN [J].
HOFMAN, FM ;
HINTON, DR ;
JOHNSON, K ;
MERRILL, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (02) :607-612
[8]  
KENNEDY MK, 1992, J IMMUNOL, V149, P2496
[9]  
LOUGHLIN AJ, 1992, IMMUNOLOGY, V75, P170
[10]  
LOUGHLIN AJ, 1993, IMMUNOLOGY, V79, P125